Yesway Puts a $300 Million Convenience-Store Roll-Up on Deck

FORT WORTH, Texas, April 20, 2026 - Yesway is bringing a real consumer-staples business to an IPO tape that still has to work for every discretionary dollar. The convenience-store operator is marketing 13,953,488 Class A shares at $20 to $23 each, a range that would raise about $279 million to $321 million before the underwriters' option.

That makes Yesway more interesting than a small placeholder filing. It is a private-equity-backed retail roll-up with scale, debt, a recognizable regional foodservice hook and a bank group that suggests a serious institutional book. Morgan Stanley is leading the offering, with J.P. Morgan and Goldman Sachs active alongside Barclays, BMO Capital Markets, KeyBanc Capital Markets, Guggenheim Securities and Raymond James.

The company has applied to list on the Nasdaq Global Select Market under YSWY. The latest prospectus still leaves the final price and delivery date blank, so the next market signal is whether investors clear the range rather than simply whether the deal appears on the calendar.

Yesway is not selling a clean deleveraging story, but the use of proceeds is close enough to matter. At the $21.50 midpoint, the company estimates net proceeds of roughly $265.5 million, or $307.6 million if the underwriters exercise the full 2,093,023-share option. The proceeds flow into newly issued LLC interests in BW Ultimate Parent, LLC. Yesway expects the parent to use $249.3 million to fully redeem outstanding redeemable senior preferred membership interests, with any remainder available for debt paydown, general corporate purposes and growth, including new store development.

The structure deserves attention. Yesway will be a holding company, and Brookwood, its sponsor, is expected to retain more than 50% of the voting power for director elections after the offering. At the midpoint, Brookwood would own 50.3% of the economic interest in BW Ultimate Parent, while the public-company issuer would hold 47.7%. Public investors are getting exposure to the operating business, but not control of it.

The operating story has enough heft to make that trade-off worth testing. Parent revenue rose to $2.67 billion in 2025 from $2.53 billion in 2024, while adjusted EBITDA increased to $186.9 million from $149.3 million. Pretax income was $32.4 million in 2025, and interest expense was still a meaningful $56.0 million. Preliminary first-quarter figures add some momentum: Yesway estimates adjusted EBITDA of $51.9 million to $60.4 million for the March 2026 quarter, compared with $27.8 million a year earlier, and total debt of $657.8 million at quarter-end.

Yesway's footprint is also more specific than the generic convenience-store label implies. As of Dec. 31, 2025, the company had 448 locations across nine states, including 447 convenience stores and one liquor store, and it expects to sell 29 Yesway-branded stores in Iowa and Kansas by the end of 2026. The remaining network is concentrated in rural and suburban markets across the Southwest and Midwest, with the Allsup's banner supplying the kind of regional brand equity that can be hard to replicate. The company says it sold more than 41 million proprietary foodservice items in 2025, including about 24 million Allsup's deep-fried burritos.

What is missing is just as important. There is no named cornerstone investor, no concurrent private placement and no explicit indication of demand in the materials. The directed share program reserves up to 5% of the offering for directors, officers, employees, business associates and related parties, but that is not the same as outside anchor demand.

That leaves Yesway as a useful test for the current IPO market. Investors are being asked to fund a scaled retail platform with improving EBITDA, a familiar bank syndicate and a tangible use of proceeds, while accepting Brookwood control, a complex LLC structure and a balance sheet that still carries real leverage. If the deal prices cleanly, it will say something about demand for profitable, cash-generating issuers outside software and biotech. If it needs a concession, the message will be just as clear.